Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.9M Sell
110,074
-36,663
-25% -$12.6M 0.4% 60
2026
Q1
$51.6M Buy
146,737
+4,299
+3% +$1.53M 0.62% 42
2025
Q4
$46.6M Buy
142,438
+7,521
+6% +$2.39M 0.53% 45
2025
Q3
$43.2M Buy
134,917
+4,018
+3% +$1.17M 0.62% 40
2025
Q2
$37.3M Buy
130,899
+15,081
+13% +$4.27M 0.58% 41
2025
Q1
$36.1M Buy
115,818
+33,622
+41% +$9.93M 0.65% 38
2024
Q4
$21.4M Buy
82,196
+9,113
+12% +$2.7M 0.37% 71
2024
Q3
$23.5M Buy
73,083
+4,640
+7% +$1.52M 0.42% 67
2024
Q2
$21.4M Buy
68,443
+280
+0.4% +$82.3K 0.46% 58
2024
Q1
$19M Buy
68,163
+7,076
+12% +$2.07M 0.43% 65
2023
Q4
$17.6M Buy
61,087
+6,908
+13% +$1.88M 0.45% 64
2023
Q3
$14.6M Buy
54,179
+7,712
+17% +$1.92M 0.46% 62
2023
Q2
$10.3M Buy
46,467
+2,610
+6% +$606K 0.34% 85
2023
Q1
$10.6M Buy
43,857
+4,183
+11% +$1.03M 0.4% 73
2022
Q4
$10.4M Buy
39,674
+2,323
+6% +$623K 0.45% 61
2022
Q3
$8.42M Buy
37,351
+563
+2% +$136K 0.4% 72
2022
Q2
$8.95M Buy
36,788
+6,069
+20% +$1.49M 0.41% 69
2022
Q1
$7.43M Buy
30,719
+17,960
+141% +$4.13M 0.33% 81
2021
Q4
$2.87M Sell
12,759
-15,073
-54% -$3.18M 0.12% 138
2021
Q3
$5.92M Buy
27,832
+980
+4% +$226K 0.35% 79
2021
Q2
$6.54M Buy
26,852
+2,474
+10% +$609K 0.5% 64
2021
Q1
$6.07M Buy
24,378
+17,111
+235% +$4.08M 0.6% 54
2020
Q4
$1.67M Buy
+7,267
New +$1.68M 0.51% 58

Other funds holding AMGN

NewEdge Wealth's AMGN Position: Q2 2026 in Review

NewEdge Wealth reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $12.6M and leaving 110,074 shares worth $39.9M. The position accounts for 0.4% of the portfolio, ranked #60.

NewEdge Wealth first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $51.6M in Q1 2026. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • NewEdge Wealth held 110,074 shares of Amgen worth $39.9M as of Q2 2026.
  • NewEdge Wealth sold 36,663 Amgen shares in Q2 2026, an estimated $12.6M.
  • Amgen made up 0.4% of NewEdge Wealth's portfolio in Q2 2026, its #60 holding.
  • NewEdge Wealth first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • NewEdge Wealth's Amgen position peaked at $51.6M in Q1 2026.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.